OR WAIT null SECS
Making the Grade: The Importance of Using the Correct Excipient Grade in Drug Products
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
Activation and expansion are essential for success in both autologous and allogeneic therapies.
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
This article explores the emergence of subjectivity in ICH Q9 (R1).
The Biosimilars Landscape
March 26, 2024
The Vacaville, Calif., site acquisition gives Lonza one of the largest biologics manufacturing sites for mammalian cell-based therapies worldwide.
In this episode of the Drug Solutions Podcast, Jan Bekkar, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
March 22, 2024
The company is recalling one lot of the product because of the potential presence of silicone particulates.
AstraZeneca’s acquisition of Amolyt Pharma includes eneboparatide, a Phase III therapeutic peptide for the treatment of hypoparathyroidism.
CDMO White Raven aims to reduce contamination risk and gain the capability to handle multiple product formats with the installation of Cytiva’s SA25 Aseptic Filling Workcell.
March 21, 2024
The conference intends to help attendees streamline their manufacturing and distribution procedures to improve patient outcomes.
More synthetic opioids have been placed under the strictest controls in the United Kingdom.
March 20, 2024
FDA's approval makes Orchard Therapeutics' Lenmeldy (atidarsagene autotemcel) the first gene therapy approved to treat pediatric metachromatic leukodystrophy in the US.
March 19, 2024
Ricoh aims to create novel disease models for R&D using ERS Genomics’ CRISPR/Cas9 genome editing technology.
March 18, 2024
Cellares CEO Fabian Gerlinghaus discusses the nuts and bolts of counterflow centrifugal elutriation and electroporation innovations and optimization, while hinting at big news on future release testing of products, as a product itself.